Viewing Study NCT01077466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2026-01-20 @ 3:41 AM
Study NCT ID: NCT01077466
Status: COMPLETED
Last Update Posted: 2012-02-17
First Post: 2010-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Natalizumab Treatment of Progressive Multiple Sclerosis
Sponsor: Rigshospitalet, Denmark
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Progressive Multiple Sclerosis View
None Secondary Progressive Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary Progressive Multiple Sclerosis View
None Secondary Progressive Multiple Sclerosis View
None Natalizumab View
None Treatment View
None Safety View
None Efficacy View
None Cerebrospinal fluid View
None Osteopontin View